Novel nanoligomer approach to treat severe COVID-19 - News-Medical.Net

Researchers discuss the biodistribution and safety of a novel nanoligomer SBCoV207, which was used to targeted miR-2392 in a murine model.

The lack of antiviral treatments for respiratory infections became evident with the emergence and worldwide spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Study: Nanolig… [+7114 chars]

full article...